| NYLIM GF US HIGH YIELD CORPORATE BONDS R USD CAP | RFI USA HIGH YIELD | -0,47% | 9,80% | 28,18% | 61,04% |
| UBS (LUX) EMERGING ECONOMIES FUND - GLOBAL BONDS (USD) I-X-ACC | RFI EMERGENTES | 10,34% | 37,72% | 28,18% | 58,28% |
| UBS (LUX) EMERGING ECONOMIES FUND - GLOBAL BONDS (USD) U-X-ACC | RFI EMERGENTES | 10,33% | 37,72% | 28,18% | 58,20% |
| AXA WORLD FUNDS-GLOBAL HIGH YIELD BONDS F CAP USD | RFI GLOBAL HIGH YIELD | 0,19% | 12,69% | 28,17% | 56,57% |
| GAM MULTISTOCK ASIA FOCUS EQUITY C USD | RVI ASIA EX-JAPÓN | 19,97% | 47,91% | 28,17% | 137,28% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO R CHF CAP | RVI EMERGENTES | 19,04% | 52,35% | 28,17% | · |
| GAM MULTISTOCK ASIA FOCUS EQUITY R USD | RVI ASIA EX-JAPÓN | 19,97% | 47,90% | 28,16% | · |
| GAM MULTISTOCK EMERGING MARKETS EQUITY E EUR | RVI EMERGENTES | 22,18% | 50,08% | 28,16% | 65,07% |
| PENTA INVERSION, FI B | ALTERNATIVOS. VOLAT.BAJA | 6,44% | 16,32% | 28,16% | 24,24% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | BIOTECNOLOGÍA | 11,99% | 5,47% | 28,16% | 58,24% |
